Molecular Breeding - Global Strategic Business Report

Global Molecular Breeding Market to Reach $27.7 Billion by 2030

The global market for Molecular Breeding estimated at US$6.5 Billion in the year 2022, is projected to reach a revised size of US$27.7 Billion by 2030, growing at a CAGR of 19.8% over the analysis period 2022-2030. Marker-Assisted Selection (MAS), one of the segments analyzed in the report, is projected to record 20.6% CAGR and reach US$10.5 Billion by the end of the analysis period. Taking into account the ongoing post pandemic recovery, growth in the QTL Mapping segment is readjusted to a revised 19.2% CAGR for the next 8-year period.

The U.S. Market is Estimated at $1.9 Billion, While China is Forecast to Grow at 18.7% CAGR

The Molecular Breeding market in the U.S. is estimated at US$1.9 Billion in the year 2022. China, the world's second largest economy, is forecast to reach a projected market size of US$4.7 Billion by the year 2030 trailing a CAGR of 18.7% over the analysis period 2022 to 2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 17.4% and 16.3% respectively over the 2022-2030 period. Within Europe, Germany is forecast to grow at approximately 13.2% CAGR.

Select Competitors (Total 32 Featured) -

• Eurofins Scientific
• Illumina
• LGC Limited
• Thermo Fisher Scientific, Inc.
• SGS SA
• DanBred
• Intertek Group Plc
• LemnaTec GmbH
• Charles River Laboratories
• Slipstream Automation
• Fruitbreedomics

What's New?

• Special coverage on Russia-Ukraine war; global inflation; easing of zero-Covid policy in China and its 'bumpy' reopening; supply chain disruptions, global trade tensions; and risk of recession.
• Global competitiveness and key competitor percentage market shares
• Market presence across multiple geographies - Strong/Active/Niche/Trivial
• Online interactive peer-to-peer collaborative bespoke updates
• Access to digital archives and Research Platform
• Complimentary updates for one year